2',2'-difluorodeoxycytidine 5'-triphosphate has been researched along with Lung Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, L; Kim, WY; Zhang, Y | 1 |
Goh, BC; Holford, NH; Lee, HS; Lee, SC; Soo, RA; Tham, LS; Wang, LZ | 1 |
2 other study(ies) available for 2',2'-difluorodeoxycytidine 5'-triphosphate and Lung Neoplasms
Article | Year |
---|---|
Systemic delivery of gemcitabine triphosphate via LCP nanoparticles for NSCLC and pancreatic cancer therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Calcium; Carcinoma, Non-Small-Cell Lung; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytidine Triphosphate; Enzyme Activation; Female; Humans; Lipids; Lung Neoplasms; Mice; Mice, Nude; Nanoparticles; Pancreatic Neoplasms; Particle Size; Phosphates; Poly(ADP-ribose) Polymerases; Polyethylene Glycols; S Phase; Static Electricity; Xenograft Model Antitumor Assays | 2013 |
Does saturable formation of gemcitabine triphosphate occur in patients?
Topics: Adipose Tissue; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Body Weight; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Creatinine; Cytidine Triphosphate; Deoxycytidine; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Models, Biological; Prodrugs; Prospective Studies; Randomized Controlled Trials as Topic | 2008 |